Rydex Biotechnology Inv RYOIX
100.48 USD +2.94 (+3.01%)
At closeNov 5, 2026, 8:10 AM EST
Day range unavailable
72.00 52-week range 100.48
- YTD
- +34.26%
- 1 year
- +28.79%
- Market cap
- 106.03M
- YTD return
- +34.26%
- 1-year return
- +28.79%
- Previous close
- 97.54
- 52-week range
- 72.00 – 100.48
YTD +22.40 (+29.81%)
Key statistics
- Enterprise value
- 0
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Short % of float
- 0.00%
- 50-day average
- 77.31
- 200-day average
- 76.52
About Rydex Biotechnology Inv
Under normal circumstances, the fund invests substantially all (at least 80%) of its net assets in equity securities of Biotechnology Companies that are traded in the United States and in derivatives, which primarily consist of futures contracts and options on securities, futures contracts, and stock indices. It may invest to a significant extent in the securities of Biotechnology Companies that have small to mid-sized capitalizations. The fund is non-diversified.
News
Your note
Sign in to keep a note on RYOIX — it syncs with the Stock Master app.